Cell & Gene Therapy
Capricor Therapeutics, Inc. news and milestones
Capricor Therapeutics, Inc.: 27 headlines on record, 14 headlines in the last 90 days. Its story counts 3 milestones.
Data updated Nov 17, 2026 · Back to the company report
27Headlines
14In 90 days
3Milestones
Headlines
Sep 302026
News · Blockonomi
Capricor (CAPR) stock rose after releasing 24-month deramiocel data from its Duchenne trial ahead of the FDA's November 22 decision deadline.
Sep 302026
News · CoinCentral
Capricor Therapeutics (CAPR) stock rose after new Phase 3 data on Duchenne drug deramiocel ahead of a November 22 FDA decision.
Sep 292026
Press release · The Globe and Mail
Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.
Sep 252026
News · NewMediaWire
NEW YORK, NY - September 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
News · NewMediaWire
NEW YORK, NY - September 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
Press release · PRNewswire
/PRNewswire/ -- SueWallSt alerts investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) that a securities class action has been filed on behalf of...
Sep 232026
News · YahooFinance
Capricor Therapeutics is back in focus after fresh analyst work led to sharply revised price targets, with some models now pointing to fair value estimates as high as US$27.00 fr…
Sep 222026
Press release · PRNewswire
/PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc....
Sep 192026
Press release · PRNewswire
/PRNewswire/ -- Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise...
Sep 172026
News · YahooFinance
- Late-Breaking Data to Include HOPE-3 Delayed-Start and Natural History Analyses Submitted in the Recent Major Amendment to the Deramiocel BLA - - PDUFA Target Action Date of No…
Sep 32026
Sep 12026
Aug 242026
Press release
- New PDUFA target action date of November 22, 2026 follows submission of additional Phase 3 HOPE-3 data and analyses supporting a refined…...
Aug 132026
Press release
Deramiocel Biologics License Application (BLA) under active FDA reviewHOPE-3 Phase 3 results published in The Lancet; primary endpoint of upper…...
Aug 102026
Press release
- Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET -SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Capricor…...
Jul 302026
Press release
SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell…...
Jul 292026
Press release
--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized,…...
Jul 272026
Press release
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell…...
Jun 262026
Press release
-Advisory Committee meeting scheduled for July 29, 2026--Company's Biologics License Application on track with PDUFA target action date…...
Jun 262026
Press release
Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE studyPUL 2.0 year-over-year decline…...
Jun 82026
Press release
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell…...
Dec 16, 20252025
News · The Globe and Mail
NewMediaWire Press Release.
Dec 10, 20252025
News · benzinga.com
Jun 15, 20252025
News · Nasdaq
High-rolling investors have positioned themselves bearish on Capricor Therapeutics (NASDAQ:CAPR), and it's important for retail traders to take note. This activity came to our at…
Nov 13, 20242024
News · Nasdaq
Analysts' ratings for Capricor Therapeutics (NASDAQ:CAPR) over the last quarter vary from bullish to bearish, as provided by 12 analysts.The table below provides a concise overvi…
News · thelancet.com
Sources: the outlets named on each headline, each story once
Milestones
Each milestone is dated by its source: registers, filings, the press
How to cite
Capricor Therapeutics, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/capricor/news
